The prognostic value of a proliferation-inducing ligand (APRIL) serum levels in treatment-naive patients with chronic lymphocytic leukemia.

CONCLUSION: sAPRIL, a simple, promising blood test, which can be measured by ELISA, will seemingly attain a place in the wide range of prognostic markers in CLL. Prospective large-scale studies are required to validate and confirm the feasibility of the proposed cut-off level of 2.04 ng/ml as a predictor of time to treatment in treatment naive CLL patients. PMID: 32950049 [PubMed - as supplied by publisher]
Source: Turkish Journal of Medical Sciences - Category: General Medicine Tags: Turk J Med Sci Source Type: research